Per Gunnar Falk
President chez Ferring Pharmaceuticals A/S
Profil
Per Gunnar Falk is currently the President & Chief Science Officer at Ferring Pharmaceuticals A.
Previously, he held positions as an Associate Director at AstraZeneca AB from 1998 to 2009, Director at Molecular Biology Consultants, Director at Recopharma AB, Director at Astra Hässle AB, and Senior VP-Biopharmaceuticals Research Unit at Novo Nordisk A.
He also served as a Principal at Gastrointestinal Associates PC, Associate Professor at Karolinska Institutet, and Member-Supervisory Board at Innate Pharma SA. Additionally, he was a Faculty Member at Umea Universitet and the University of Gothenburg.
Dr. Falk obtained a doctorate degree from the University of Gothenburg.
Postes actifs de Per Gunnar Falk
| Sociétés | Poste | Début |
|---|---|---|
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | President | 01/01/2019 |
Anciens postes connus de Per Gunnar Falk
| Sociétés | Poste | Fin |
|---|---|---|
| Novo Nordisk North America, Inc. | Directeur Technique/Scientifique/R&D | 03/01/2011 |
| INNATE PHARMA | Directeur/Membre du Conseil | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
| Molecular Biology Consultants | Directeur/Membre du Conseil | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Directeur/Membre du Conseil | - |
Formation de Per Gunnar Falk
| University of Gothenburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| INNATE PHARMA | Health Technology |
| Entreprise privées | 7 |
|---|---|
Recopharma AB
 Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
Gastrointestinal Associates PC
 Gastrointestinal Associates PC Medical/Nursing ServicesHealth Services Gastrointestinal Associates PC provides treatment for gastrointestinal problems. The private company is based in Knoxville, TN. | Health Services |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| Astra Hässle AB | |
| Molecular Biology Consultants | |
| Novo Nordisk North America, Inc. | |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Health Technology |